Precision Therapeutics to Report Fiscal Year 2018 Financial Results and Provide Company Update on Monday, April 1, 2019

by NASDAQ Market News March 25, 2019

NASDAQ Market News
Click here to email author

Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback

CytomX Therapeutics Announces Transition of Chief Financial Officer

Ads